Imprimis Pharma (IMMY) Reports Q3 Loss of $0.29/Share

Imprimis Pharma (NASDAQ: IMMY) reported Q3 EPS of ($0.29), versus ($0.41) reported last year. Revenue for the quarter came in at $4.9 million, versus $2.7 million reported last year.

For earnings history and earnings-related data on Imprimis Pharma (IMMY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c